RSS   Newsletter   Contact   Advertise with us

Smiths Group appoints Pam Cheng as independent non-executive director

Christian Fernsby | London, United Kindom | July 26, 2019
Pam ChengSmiths Group, a technology company, announced the appointment of Pam Cheng as an independent non-executive director.
The appointment will take effect from 1 March 2020.

On joining the Board Ms. Cheng will become a member of the Nomination and Governance, Audit and Risk and Remuneration Committees.

Ms. Cheng, Executive Vice-President, Operations and Information Technology, joined AstraZeneca in June 2015 after having spent 18 years in Global Manufacturing, Supply Chain and Commercial roles at Merck/MSD.

Ms. Cheng was President of MSD China, responsible for MSD's entire business in China prior to joining AstraZeneca.

She was the Head of Global Supply Chain Management and Logistics for Merck from 2006 to 2011 and led the transformation of Merck supply chains across the global supply network.

Prior to joining Merck, Ms. Cheng held various engineering and project management positions at Universal Oil Products, Union Carbide Corporation and GAF Chemicals.

She is also an independent non-executive Director of the US listed company Codexis Inc.

Ms. Cheng holds Bachelor's and Master's degrees in chemical engineering from Stevens Institute of Technology in New Jersey and an MBA in marketing from Pace University in New York.